Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 10-K Report Annual Report
  2. 8-K Event Exit or restructuring costs
  3. 4 Grant or award Director acquired 17,857 shares (grant or award)
  4. 4 Open-market sale Director sold 600,000 shares at an average $0.35 ($207,720)
  5. 4 Open-market sale Director sold 745,892 shares at an average $0.38 ($285,125)
  6. 8-K Event Delisting notice
  7. SC 13D/A Stake Beneficial Ownership Report
  8. 4 Open-market sale Director sold 1,523,346 shares at an average $0.37 ($570,155)
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 4 Open-market sale Director sold 1,430,753 shares at an average $0.43 ($609,169)
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 4 Open-market sale Director sold 3,078,820 shares at an average $0.48 ($1,474,249)
  13. 4 Open-market sale Director sold 1,173,582 shares at an average $0.44 ($515,106)
  14. SC 13D/A Stake Beneficial Ownership Report
  15. 4 Open-market sale Director sold 1,513,088 shares at an average $0.49 ($734,189)
  16. 4 Open-market sale Director sold 100,000 shares at $0.41 ($41,400)
  17. 4 Open-market sale Director sold 1,223,936 shares at an average $0.43 ($521,987)
  18. 4/A Open-market sale Director sold 188,322 shares at $0.55 ($103,050)
  19. SC 13D/A Stake Beneficial Ownership Report
  20. 4 Open-market sale Director sold 188,322 shares at $0.55 ($103,050)

Page 35 of 62 · 1,224 filings